Our Business

Innoviva is a diversified biopharmaceutical company with three primary divisions

Strategic Assets

Royalty Portfolio

Well-characterized revenues from durable, resilient royalty assets ensure strong cashflow generation in addition to significant downside protection

Long-term strategic partner with commitment spanning years

Interest in and differentiated ability to help companies succeed

Critical Care and Infectious Disease Therapeutics

High-growth critical care and infectious disease platform anchored by a diverse portfolio of best-in-class marketed products and a promising late-stage pipeline

Learn more at Innoviva Specialty Therapeutics

Long-term strategic partner with commitment spanning years

Interest in and differentiated ability to help companies succeed

Strategic Healthcare Assets

A promising portfolio of assets with asymmetric pay-offs provide for significant upside potential

Long-term strategic partner with commitment spanning years

Interest in and differentiated ability to help companies succeed

Critical Care and ID Therapeutics

Robust integrated biopharma platform anchored by 2 best in class marketed products and a promising late-stage pipeline.

Learn more at Innoviva Specialty Therapeutics

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industrys standard dummy text ever since the 1500s.